Applied Biosciences Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APPB research report →
Companywww.appliedbiocorp.com
Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It also delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers.
- CEO
- Christopher Michael Bridges
- IPO
- 2016
- Employees
- 25
- HQ
- Beverly Hills, CA, US
Price Chart
Valuation
- Market Cap
- $1.36K
- P/E
- -0.00
- P/S
- 0.02
- P/B
- -0.00
- EV/EBITDA
- -0.38
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -358.52%
- Op Margin
- -781.32%
- Net Margin
- -865.30%
- ROE
- 93.90%
- ROIC
- -99.07%
Growth & Income
- Revenue
- $88.67K · -87.74%
- Net Income
- $-767,220 · 83.58%
- EPS
- $-0.04 · 88.38%
- Op Income
- $-692,756
- FCF YoY
- 39.73%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 732.83
- Avg Volume
- 3
Get TickerSpark's AI analysis on APPB
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 3, 19 | Beaubaire Michael | other | 0 |
| Sep 13, 19 | Brady John Robert | other | 100,000 |
| May 28, 19 | Urbanski Raymond W. | other | 0 |
| May 28, 19 | Urbanski Raymond W. | other | 0 |
| Apr 15, 19 | Stevens Scott B | other | 0 |
| Apr 15, 19 | Stevens Scott B | other | 0 |
| Apr 15, 19 | Stevens Scott B | other | 0 |
| Mar 14, 19 | Bridges Chris | sell | 116,664 |
| Oct 1, 18 | Bridges Chris | other | 200,000 |
| Aug 24, 18 | Bridges Chris | sell | 25,000 |
Our APPB Coverage
We haven't published any research on APPB yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate APPB Report →